This article is designed to refresh and update the community emergency physician knowledge base for the assessment and management of pediatric chest trauma.
Disruptive behaviors are a poor prognostic sign in patients with Alzheimer's disease.
Wyeth Pharmaceuticals has received approval to market desvenlafaxine for the treatment of depression. The drug is the major active metabolite of venlafaxine (Effexor ). Wyeth has formulated the drug in a once-daily extended-release tablet. It will be marketed under the trade name Pristiq.
Lower serum testosterone in men aged 60 and over was associated with increased fracture risk (especially hip and nonvertebral), even after adjusting for other major risk factors for fracture.
Neither training in working techniques nor use of lifting equipment appears to prevent back pain or back-related disability.
This single center prospective observational study finds that the utility of a routine daily chest x-ray (CXR) for an ICU patient is quite limited. A change in practice to ordering CXR only when clinically indicated did not adversely impact patient outcome but reduced CXR volume and overall costs.
The greatest challenge for any potentially mortal disorder is to prove that therapeutic interventions reduce not only disease-specific mortality, but also all-cause mortality.
Metabolomic profiling is a technique that measures and analyzes a large array of low molecular weight species in any chosen sample. Metabolomic analysis of plasma accurately distinguishes between subjects with Parkinson disease and healthy controls, thus providing a potential disease biomarker.
